Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent
Sometimes stocks making big moves have been hit with an
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.
With that in mind, let's take a closer look at a
is a biotechnology company focused on expanding its genetic testing and reproductive service businesses in the Asia-Pacific region. This stock is trading up 19% at $4.08 in recent trading.
Today's Range: $3.70-$4.22
52-Week Range: $2.29-$6.20
Volume: 2.2 million
Three-Month Average Volume: 176,106
Shares of GENE are exploding higher today after the company announced that its breast cancer risk test has been cleared for sale into Florida.
From a technical perspective, GENE is gapping up sharply here right off both its 50-day and 200-day moving averages at $3.41 with heavy volume. This move has also pushed GENE into near-term breakout territory, since the stock is pushing above some overhead resistance at $3.71.
Traders should now look for long-biased trades in GENE once it triggers its next major breakout trade. That trade will hit once GENE manages to clear some key overhead resistance levels at $4.28 to $4.79 with high volume. Look for a sustained move or close above those levels with volume that's near or above 176,106 shares. If that breakout triggers soon, then GENE will have a great chance to re-test or possibly take out its next major overhead resistance at $6.20.
is an integrated China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against infectious diseases. This stock is trading up 9.4% at $2.72 in recent trading.
Today's Range: $2.55-$2.82
52-Week Range: $1.64-$2.88
Three-Month Average Volume: 61,992
From a technical perspective, SVA is gapping up sharply here with above-average volume, and it's starting to break out above some near-term overhead resistance levels at $2.64 to $2.75.
Traders should now watch for the next major breakout trade to trigger for SVA. That trade will hit once SVA manages to clear some past overhead resistance at $2.88 with high volume. You can look for long-biased trades in SVA as long as it's trending above today's low of $2.56, and then once it sustains a move or close above $2.88 with volume that's near or above 61,992 shares. If that breakout triggers soon, then SVA will setup to re-test or possibly take out its next major overhead resistance at $3.33.
is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. This stock is trading up 3.6% to $2.04 in recent trading.
Today's Range: $1.91-$2.10
52-Week Range: $1.21-$16.56
Volume: 1.6 million
Three-Month Average Volume: 891,209
From a technical perspective, BPAX is moving notably higher here with above-average volume. This move is quickly pushing BPAX within range of triggering a near-term breakout trade. That trade will hit once BPAX manages to take out some near-term overhead resistance at $2.20 to $2.24 with high volume.
Traders should now look for long-biased trades in BPAX once it manages to clear those breakout levels with volume that's near or above 891,209 shares. If that breakout triggers soon, then BPAX will setup to re-test or possibly take out its next major overhead resistance levels at $2.94 to its 200-day moving average of $3.19.
is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. This stock is trading up 3.7% to $5.61 in recent trading.
Today's Range: $5.50-$5.77
52-Week Range: $1.58-$5.94
Three-Month Average Volume: 1 million
From a technical perspective, ARRY is bouncing solidly higher here right off some near-term support at $5.40 with decent volume. This move is quickly pushing ARRY within range of triggering a major breakout trade. That trade will hit once ARRY manages to take out some key overhead resistance levels at $5.85 to $5.94 with high volume.
Traders should now look for long-biased traders in ARRY as long as it's trending above its 50-day at $5.12, and then once it sustains a move or close above those breakout levels with volume that's near or above 1 million shares. If that breakout triggers soon, then ARRY will setup to tag its next significant overhead resistance level at $8.
To see more stocks under-$10 that are making notable moves higher today, check out the
portfolio on Stockpickr.
-- Written by Roberto Pedone in Winderemere, Fla.
Follow Stockpickr on
and become a fan on
As of the time of publication, the author had no positions in stocks mentioned.
Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to Beconequity.com and maintains the website Maddmoney.net, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.